249 related articles for article (PubMed ID: 15647778)
21. Candesartan effect on inflammation in hypertension.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Hypertens Res; 2010 Mar; 33(3):209-13. PubMed ID: 20075928
[TBL] [Abstract][Full Text] [Related]
22. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
[TBL] [Abstract][Full Text] [Related]
23. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.
Mugellini A; Preti P; Zoppi A; Corradi L; Fogari E; Derosa G; Fogari R
J Hum Hypertens; 2004 Oct; 18(10):687-91. PubMed ID: 15071488
[TBL] [Abstract][Full Text] [Related]
24. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy.
Bönner G;
Blood Press Suppl; 2008 Dec; 2():22-30. PubMed ID: 19203019
[TBL] [Abstract][Full Text] [Related]
26. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
27. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
Karlson BW; Zetterstrand S; Olofsson B; Elmfeldt D
Blood Press; 2009; 18(3):149-56. PubMed ID: 19462314
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
29. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
30. Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.
Koh KK; Quon MJ; Lee Y; Han SH; Ahn JY; Chung WJ; Kim JA; Shin EK
Eur Heart J; 2007 Jun; 28(12):1440-7. PubMed ID: 17483542
[TBL] [Abstract][Full Text] [Related]
31. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Rosei EA; Rizzoni D; Muiesan ML; Sleiman I; Salvetti M; Monteduro C; Porteri E;
J Hypertens; 2005 Feb; 23(2):435-44. PubMed ID: 15662233
[TBL] [Abstract][Full Text] [Related]
32. Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Itoh H
Am J Nephrol; 2006; 26(5):462-8. PubMed ID: 17063001
[TBL] [Abstract][Full Text] [Related]
33. Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.
Andersen NH; Poulsen PL; Knudsen ST; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Mogensen CE
Diabetes Care; 2005 Feb; 28(2):273-7. PubMed ID: 15677778
[TBL] [Abstract][Full Text] [Related]
34. Hydrochlorothiazide compared to candesartan treatment increases adipose tissue gene expression and circulating levels of serum amyloid A in hypertensive patients.
Palming J; Jansson PA; Renström F; Johansson A; Johansson L; Karlsson C; Lind L; Eriksson JW
Horm Metab Res; 2011 May; 43(5):319-24. PubMed ID: 21332024
[TBL] [Abstract][Full Text] [Related]
35. Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria.
Morgan T; Anderson A; Bertram D; MacInnis RJ
J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):64-71. PubMed ID: 15295717
[TBL] [Abstract][Full Text] [Related]
36. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Derosa G; Cicero AF; Ciccarelli L; Fogari R
Clin Ther; 2003 Jul; 25(7):2006-21. PubMed ID: 12946547
[TBL] [Abstract][Full Text] [Related]
38. The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design.
Chaturvedi N; Sjoelie AK; Svensson A;
J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):255-61. PubMed ID: 12584669
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of candesartan cilexetil in hypertensive patients with or without diabetes].
El Féghali R; Nisse-Durgeat S; Asmar R
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):679-82. PubMed ID: 17928776
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.
Izzo JL; Weinberg MS; Hainer JW; Kerkering J; Tou CK;
J Clin Hypertens (Greenwich); 2004 Sep; 6(9):485-93. PubMed ID: 15365275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
